semaglutide chattanooga tn TennCare's obesity medication coverage is a win for Tennesseans • Tennessee Lookout Week 2 on Semaglutide: Injection

Despite limited data from clinical trials on the use of MS DMTs in people aged 50 years, these treatments are widely used among this group and questions around optimal use, discontinuation and monitoring remain unanswered

As for macronutrients, a lot of attention has been put on protein, as GLP-1 drug users seek to maintain lean body mass as they lose weight, he said

The most commonly reported side effect is nausea, especially in the first hour after a dose

If someone weighs 250 pounds and puts that number directly into a protein calculator, the target can seem too hard to reach, especially if they don't feel hungry

A stepwise approach prioritizing safety and tolerability is recommended